Disclosed are compounds of formula (I) ##STR00001## Where Ar.sub.1, X, Y, Q, W, R.sup.3, R.sup.4, R.sup.5, R.sup.6 and R.sup.y are defined herein. The compounds of the invention inhibit production of cytokines involved in inflammatory processes and are thus useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease. The compounds are also useful for treating diseases or conditions related to oncology and anticoagulant or fibrinolytic therapy. Also disclosed are processes for preparing these compounds and pharmaceutical compositions comprising these compounds.

 
Web www.patentalert.com

< Selectable gene marker system based on expression of N-acetyllactosaminide 3-.alpha. galactosyltransferase

< Compositions and methods for treating or preventing convulsions or seizures

> UDP-N-acetylglucosamine: galactose-.beta.1,3-N-acetylgalactosamine-.alpha.-R/ (GlcNAc to GalNAc) .beta.1,6N-acetylglucosaminyltransferase, C2GnT3

> Thermostable reverse transcriptases and uses thereof

~ 00276